Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of DA-5218 in adults with Type 2 diabetes mellitus is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DA-5218 (DA-5218)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Diabete Mellitus | Phase 4 | Status: NOT_YET_RECRUITING